Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Healthcare

Page 39
  1. Apr 01, 2026 · 07:30 · NPTH · Neutral

    NEUPATH HEALTH ANNOUNCES PROPOSED SHARES FOR DEBT SETTLEMENT

    NEUPATH HEALTH ANNOUNCES PROPOSED SHARES FOR DEBT SETTLEMENT

    01
  2. Apr 01, 2026 · 07:28 · CRDL · Neutral

    Cardiol Therapeutics Announces Year-End 2025 Update on Operations

    Cardiol Therapeutics Announces Year-End 2025 Update on Operations

    02
  3. Mar 31, 2026 · 20:55 · BCT

    Briacell completes licence acquisition by BriaPro

    Briacell completes licence acquisition by BriaPro

    03
  4. Mar 31, 2026 · 20:03 · INNO

    Innocan arranges $200,000 (U.S.) debenture offering

    Innocan arranges $200,000 (U.S.) debenture offering

    04
  5. Mar 31, 2026 · 19:43 · 4565 · Routine +

    Not provided in data

    Nxera Pharma's Partner Centessa Pharmaceuticals to be Acquired by Lilly

    05
  6. Mar 31, 2026 · 19:10 · RVX · Routine −

    Audit Delays and MCTO Mask Existential Liquidity Crisis at Resverlogix

    Resverlogix Corp. Provides Bi-Weekly MCTO Status Update

    06
  7. Mar 31, 2026 · 18:23 · MVMD

    Mountain Valley arranges offering, two debt settlements

    Mountain Valley arranges offering, two debt settlements

    07
  8. Mar 31, 2026 · 18:10 · IOT · Routine +

    Innovotech Posts First Profitable Year as Stock Slides to Lows, Masking Thin Margins and Liquidity Risks

    Innovotech Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results

    08
  9. Mar 31, 2026 · 18:10 · NXG · Routine +

    Steady Growth Masks High Payout Ratio and Micro-Cap Liquidity Risks

    NexgenRx Announces 2025 Year End Results with Continued Increasing Net Income, EBITDA And Revenue Growth

    09
  10. Mar 31, 2026 · 17:22 · APS · Routine +

    Aptose Shareholders Approve C$2.41 Hanmi Buyout as Clinical Data Validates Triplet Strategy

    Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights

    10
  11. Mar 31, 2026 · 17:21 · TELO

    Telo Genomics appoints Farlinger as CEO, chairman

    Telo Genomics appoints Farlinger as CEO, chairman

    11
  12. Mar 31, 2026 · 16:15 · PINK · Routine +

    Perimeter Clears FDA Hurdle and Posts Record Sales, But Cash Runway and Dilution Threaten Near-Term Upside

    Perimeter Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results Marked by Record Revenues and Improved Operating Performance

    12
  13. Mar 31, 2026 · 16:05 · BCT · Neutral

    Internal License Transfer Closes as BriaCell Consolidates Pipeline Amid Cash Burn and Dilution Overhang

    BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

    13
  14. Mar 31, 2026 · 15:32 · THRM

    Therma Bright wins order for 100 Venowave units

    Therma Bright wins order for 100 Venowave units

    14
← Newer Older →